Tech Company Financing Transactions
XCures Funding Round
On 6/25/2026, XCures announced $46 million in Series B funding from Innovius, GKCC LLC and iGrow Venture Partners.
Transaction Overview
Company Name
Announced On
6/25/2026
Transaction Type
Venture Equity
Amount
$46,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to support the continued expansion of the clinical clarity layer to turn fragmented medical records into decision-ready clinical data.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
1901 Harrison St. 1100
Oakland, CA 94612
USA
Oakland, CA 94612
USA
Phone
Website
Email Address
Overview
The convergence of genomics, precision medicine, and AI have created an unprecedented moment in the world of oncology. But the drug-centric way in which treatments are developed and the haphazard way in which knowledge about those treatments is captured and delivered to the point of care does not serve patients well.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Marty Tenenbaum
Chief Executive Officer
Mika Newton
Chief Medical Officer
Santosh Kesari
Chief Technical Officer
Glenn Kramer
Vice President
Mark Shapiro
VP - Product Management
Kenny Wong
VP - R & D
Jeffrey Shrager
Browse more venture capital transactions:
Prev: 6/25/2026: GrailPay venture capital transaction
Next: 6/25/2026: Leyden Labs venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. All VC database entries reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs